SEC Form 4 · accession 0001209191-17-007876

HCA Healthcare, Inc. · HCA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Group President

Period of report

Feb 1, 2017

Accepted (ET)

Feb 3, 2017 · 7:16 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000860730

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 2, 2017	M	84,464	$13.2075	A	92,519	D
Common Stock	Feb 2, 2017	M	15,536	$17.6471	A	108,055	D
Common Stock^F1	Feb 2, 2017	S	100,000	$82.3843	D	8,055	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Appreciation Right^F2	$81.96	Feb 1, 2017	A	27,510	A	Feb 1, 2018	Feb 1, 2027	Common Stock	27,510	27,510	D
Non-Qualified Stock Option (right to buy)^F3,F4	$13.2075	Feb 2, 2017	D	84,464	D	Nov 17, 2011	Oct 6, 2019	Common Stock	84,464	0	D
Non-Qualified Stock Option (right to buy)^F3,F4	$17.6471	Feb 2, 2017	D	15,536	D	Nov 17, 2010	Oct 6, 2019	Common Stock	15,536	68,914	D

F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $82.25 to $82.76, inclusive. The reporting person undertakes to provide to HCA Holdings, Inc., any security holder of HCA Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2The stock appreciation rights vest in four equal annual installments beginning on February 1, 2018.
F3Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.
F4Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.